gip and glp-1 receptor agonist Agonists – Peripheral Brain Quintuple GLP-1–GIP–PPAR agonist for obesity

The landmark SURMOUNT-1 trial demonstrated that participants receiving the highest dose of tirzepatide lost up to 22.5% of their total body weight over 72 weeks

Dendritic spines: revisiting the physiological role

The direct and weight-independent actions of some new obesity pharmacotherapies in ectopic fat of specific organs may further enhance the potential for tailored treatment choices based on patients complications

I love Ortho Molecular - L-Carnitine (its avail in my dispensary, Sis!) Share this with your Bestie whos struggling to lose weight in Perimenopause xoxo Dr

These include decreased exercise tolerance and dyspnea with exertion